Professor Wen Jiang
(he/him)

MBE, MB, BCh, MD, FRSB, FLSW

: Available for postgraduate supervision

Teams and roles for Wen Jiang

Chair
School of Medicine

I have a long-standing interest in cancer metastasis and from 1987, my main research interest has been on the molecular and cellular basis of cancer invasion and metastasis and therapeutic aspects of targeting cancer metastasis. I have been particularly interested in the bone, peritoneal and brain metastasis from primary tumours including breast, prostate, lung, GI cancers. My research has been conducted in Cardiff's School of Medicine and I have collaborated widely with colleagues in the UK, China, Europe, North America and Asia.

Date
Type

2000

Davies, G. , Jiang, W. G. and Mason, M. D. 2000. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells.. Journal of Urology 163 (3), pp.985-992.
Hiscox, S. E. et al. 2000. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4. British Journal of Cancer 59 (3), pp.245-254. (10.1023/A:1006348317841)
Hoppe, A. et al., 2000. Interactive image processing system for assessment of cell movement.. Medical and Biological Engineering and Computing 37 (4), pp.419-423.
Jiang, W. G. , Eynard, A. R. and Mansel, R. E. 2000. The pathology of essential fatty acid deficiency: is it cell adhesion mediated?. Medical Hypothesis 55 , pp.257-262. (10.1054/mehy.1998.1191)
Jiang, W. G. and Mansel, R. E. 2000. E-cadherin complex and its abnormalities in human breast cancer. Surgical Oncology 9 , pp.151-171.
Jiang, W. G. and Mansel, R. E. 2000. Metastatic cascade, molecular/cellular events. In: Jiang, W. G. and Mansel, R. E. eds. Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention. Cancer Metastasis - Biology and Treatment Vol. 1.Dordrecht, Netherlands: Kluwer Academic Publishers. , pp.1-18.
Jiang, W. G. , Martin, T. and Mansel, R. E. 2000. Tight junction, a critical structure in the control of cancer invasion and metastasis. In: Jiang, W. G. and Mansel, R. E. eds. Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention. Cancer Metastasis - Biology and Treatment Vol. 1.Dordrecht, Netherlands: Kluwer Academic Publishers. , pp.195-214.
Jiang, W. G. et al. 2000. Polyunsaturated fatty acids and their role in cancer invasion and metastasis. In: Jiang, W. G. and Mansel, R. E. eds. Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention. Cancer Metastasis - Biology and Treatment Vol. 1.Dordrecht, Netherlands: Kluwer Academic Publishers. , pp.225-253.
Jiang, W. G. et al. 2000. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) mediates the action of gamma linolenic acid in breast cancer cells.. Prostaglandins Leukotrienes & Essential Fatty Acids 62 (2), pp.119-127. (10.1054/plef.1999.0131)
Parr, C. et al. 2000. NK4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. International Journal of Cancer 85 (4), pp.563-570. (10.1002/(SICI)1097-0215(20000215)85:4<563::AID-IJC19>3.0.CO;2-D)

1999

Cai, J. , Jiang, W. and Mansel, R. 1999. Inhibition of angiogenic factor- and tumour-induced angiogenesis by gamma linolenic acid. Prostaglandins Leukotrienes & Essential Fatty Acids 60 (1), pp.21-29. (10.1054/plef.1998.0004)
Cai, J. , Jiang, W. and Mansel, R. 1999. Inhibition of the expression of VE-cadherin/catenin complex by gamma linolenic acid in human vascular endothelial cells, and its impact on angiogenesis. Biochemical and Biophysical Research Communications 258 (1), pp.113-118. (10.1006/bbrc.1999.0596)
Cai, J. , Jiang, W. and Mansel, R. 1999. Phosphorylation and disorganization of vascular-endothelial cadherin in interaction between breast cancer and vascular endothelial cells. International Journal of Molecular Medicine 4 (2), pp.191-195. (10.3892/ijmm.4.2.191)
Davies, E. L. et al., 1999. The immunohistochemical expression of desmoplakin and its role in vivo in the progression and metastasis of breast cancer. European Journal of Cancer 35 (6), pp.902-907. (10.1016/S0959-8049(99)00031-3)
Davies, G. et al., 1999. HGF/SF influences the interaction between APC, GSK3 beta and beta-catenin, its impact on cell adhesion and in vitro invasion in prostate cancer. British Journal of Cancer 80 (Supp 2), pp.36-36.
Davies, G. , Jiang, W. G. and Mason, M. D. 1999. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion.. Anticancer Research 19 (1A), pp.547-552.
Hiscox, S. E. and Jiang, W. G. 1999. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochemical and Biophysical Research Communications 261 (2), pp.406-411. (10.1006/bbrc.1999.1002)
Hiscox, S. E. and Jiang, W. G. 1999. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin. Journal of Cell Science 112 (18), pp.3081-3090.
Hiscox, S. E. and Jiang, W. G. 1999. Hepatocyte growth factor scatter factor disrupts epithelial tumour cell-cell adhesion: involvement of beta-catenin. Anticancer Research 19 (1A), pp.509-517.
Hiscox, S. E. , Mansel, R. E. and Jiang, W. G. 1999. Ezrin regulates cell-cell adhesion and motility and associates with intercellular junctional proteins in cancer cells. British Journal of Cancer 81 (4), pp.579-579. (10.1038/sj.bjc.6690733)
Jiang, W. G. et al. 1999. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Critical Reviews in Oncology/Hematology 29 (3), pp.209-248.
Jiang, W. G. et al. 1999. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clinical Cancer Research 5 (11), pp.3695-3703.
Jiang, W. G. et al. 1999. Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells.. Journal of Cellular Physiology 181 (2), pp.219-329. (10.1002/(SICI)1097-4652(199911)181:2<319::AID-JCP14>3.0.CO;2-S)

1998

Cai, J. , Jiang, W. and Mansel, R. 1998. Gap junctional communication and the tyrosine phosphorylation of connexin 43 in interaction between breast cancer and endothelial cells. International Journal of Molecular Medicine 1 (1), pp.273-278. (10.3892/ijmm.1.1.273)
Davies, E. L. et al., 1998. The expression of desmoglein-2 in primary breast cancer and its relation to a series of prognostic markers [Abstract]. British Journal of Cancer 78 (2), pp.149. (10.1038/bjc.1998.457)
Davies, G. , Jiang, W. G. and Mason, M. D. 1998. E-cadherin and associated molecules in the invasion and progression of prostate cancer. Oncology Reports 5 (6), pp.1567-1576. (10.3892/or.5.6.1567)
Eynard, A. R. , Jiang, W. G. and Mansel, R. E. 1998. Eicosatrienoic acid (20:3 n-9) inhibits the expression of E-cadherin and desmoglein in human squamous cell carcinoma in vitro.. Prostagladins Leukotrienes and Essential Fatty Acids 59 (6), pp.371-377. (10.1016/S0952-3278(98)90098-9)
Eynard, A. R. , Jiang, W. G. and Mansel, R. E. 1998. Eicosatrienoic acid (20:3, n-9) regulate the expression of E-cadherin and desmoglein in squamous cell carcinoma. Presented at: 17th International Cancer Congress Rio de Janeiro, Brazil 24-28 August 1998. Published in: Moraes, M. , Brentani, R. and Bevilacqua, R. eds. Proceedings of the 17th International Cancer Congress. Bologna: Medimond. , pp.233-238.
Hiscox, S. E. , Davies, E. and Jiang, W. G. 1998. Up-regulation of the expression of hepatocyte growth factor activator (HGFA) in breast cancer. British Journal of Cancer 78 (2), pp.150-150. (10.1038/bjc.1998.457)
Hoppe, A. and Jiang, W. G. 1998. A system for computer analysis of cancer cell movement. Anticancer Research 18 , pp.2691-2694.
Jiang, W. G. 1998. Cell adhesion molecules in the formation of liver metastasis. Journal of Hepato-Biliary-Pancreatic Surgery 5 (4), pp.371-377. (10.1007/s005340050061)
Jiang, W. G. 1998. Regulation of cell adhesion, a central mechanism in the anticancer action of essential fatty acids. International Journal of Molecular Medicine 1 (3), pp.621-625.
Jiang, W. G. and Bryce, R. P. 1998. Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Critical Reviews in Oncology/Hematology 27 , pp.179-209.
Jiang, W. G. et al. 1998. gamma-Linolenic acid blocks cell cycle progression by regulating phosphorylation of p27kip1 and p57kip2 and their interactions with other cycle regulators in cancer cells.. International Journal of Oncology 13 (3), pp.611-617.
Jiang, W. G. and Harding, K. G. 1998. Enhancement of wound tissue expansion and angiogenesis by matrix-embedded fibroblast (dermagraft), a role of hepatocyte growth factor/scatter factor. International Journal of Molecular Medicine 2 , pp.203-210.
Jiang, W. G. and Hiscox, S. 1998. Association of PTPmu with catenins in cancer cells: a possible role for E-cadherin. International Journal of Oncology 13 , pp.1077-1080.
Jiang, W. G. et al. 1998. The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells. British Journal of Cancer 77 (5), pp.731-738. (10.1038/bjc.1998.120)
Jiang, W. G. et al. 1998. Essential fatty acids regulate the expression of tumour suppressor genes in cancer cells. Presented at: Fourth International Congress on Essential Fatty Acids and Eicosanoids Edinburgh, UK 20-24 July 1997. Published in: Riemersma, R. A. et al., Essential fatty acids and eicosanoids: invited papers from the Fourth International Congress. Champaign, Illinois: AOCS Press. , pp.303-311.

1997

Davies, E. et al. 1997. The role of desmoglein 2 and E-cadherin in the invasion and motility of human breast cancer cells. International Journal of Oncology 11 (2), pp.415-419.
Hiscox, S. and Jiang, W. G. 1997. Interleukin-12, an emerging anti-tumour cytokine. In Vivo -Athens- 11 , pp.125-132.
Hiscox, S. E. et al. 1997. Expression of the HGF/SF Receptor, c-met, and its ligand in human colorectal cancers. Cancer Investigation 15 (6), pp.513-521. (10.3109/07357909709047592)
Hiscox, S. E. and Jiang, W. G. 1997. Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor. Biochemical and Biophysical Research Communications 233 (1), pp.1-5. (10.1006/bbrc.1997.6388)
Jiang, W. G. and Bryce, R. P. 1997. Gamma linolenic acid regulates gap junction communication in endothelial cells and their interaction with tumour cells. Prostaglandins Leukotrienes & Essential Fatty Acids 56 , pp.307-316.
Jiang, W. G. and Bryce, R. P. 1997. Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochemical and Biophysical Research Communications 244 , pp.414-420.
Jiang, W. G. and Hiscox, S. 1997. Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer. Anticancer Research 17 , pp.1349-1354.
Jiang, W. G. and Hiscox, S. 1997. Quantification of tumour cell-endothelial cell attachment by 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine (DiI). Cancer Letters 112 (2), pp.209-217. (10.1016/S0304-3835(96)04573-9)
Jiang, W. G. and Hiscox, S. E. 1997. beta-catenin-cell adhesion and beyond (review). International Journal of Oncology 11 (3), pp.635-641.
Jiang, W. G. and Hiscox, S. E. 1997. Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles. Histology and Histopathology 12 (2), pp.537-555.
Jiang, W. G. et al. 1997. Gamma linolenic acid regulates expression of maspin and the motility of cancer cells. Biochemical and Biophysical Research Communications 237 (3), pp.639-644. (10.1006/bbrc.1997.7154)
Jiang, W. G. and Puntis, M. C. 1997. Immune dysfunction in patients with obstructive jaundice, mediators and implications for treatments. HPB Surgery 10 , pp.129-142.
Jiang, W. G. et al. 1997. Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids. Clinical and Experimental Metastasis 15 (6), pp.593-602. (10.1023/A:1018435229087)

1996

Han, Z. et al., 1996. Inhibition of motility and invasion of human lung cancer cells by invasion inhibiting factor 2. Surgical Oncology 5 (2), pp.77-84. (10.1016/S0960-7404(96)80004-1)
Jiang, W. G. 1996. E-cadherin and its associated protein catenins, cancer invasion and metastasis. British Journal of Surgery 83 , pp.437-446.
Jiang, W. G. et al. 1996. Hepatocyte growth factor induces tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin and enhances cell-matrix interactions. Oncology Reports 3 (5), pp.819-823. (10.3892/or.3.5.819)
Jiang, W. G. et al. 1996. Gamma linolenic acid inhibits tyrosine phosphorylation of focal adhesion kinase and paxillin and tumour cell matrix interaction. International Journal of Oncology 8 (3), pp.583-587. (10.3892/ijo.8.3.583)
Jiang, W. G. et al. 1996. Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid. International Journal of Oncology 9 (2), pp.279-284. (10.3892/ijo.9.2.279)
Jiang, W. G. and Hiscox, S. E. 1996. Cytokine regulation of ezrin expression in the human colon cancer cell line HT29.. Anticancer Research 16 (2), pp.861-865.
Jiang, W. G. and Puntis, M. C. 1996. Monocyte and blood interleukin-12 levels in patients with obstructive jaundice. Hpb Surgery 9 (4), pp.209-221.
Jiang, W. G. et al. 1996. Inhibition of neutrophil respiratory burst and cytokine priming by γ-linolenic acid. British Journal of Surgery 83 (5), pp.659-664. (10.1002/bjs.1800830523)
Puntis, M. C. A. and Jiang, W. G. 1996. Plasma cytokine levels and monocyte activation in patients with obstructive jaundice. Journal of Gastroenterology and Hepatology 11 , pp.7-13. (10.1111/j.1440-1746.1996.tb00003.x)

1995

Hiscox, S. et al., 1995. Inhibition of cancer cell motility and invasion by interleukin-12. Clinical & Experimental Metastasis 13 (5), pp.396-404. (10.1007/BF00121916)
Jiang, W. G. 1995. Membrane ruffling of cancer cells: a parameter of tumour cell motility and invasion. European Journal of Surgical Oncology (EJSO) 21 , pp.307-309. (10.1016/S0748-7983(95)91690-3)
Jiang, W. G. et al. 1995. Gamma linolenic acid up-regulates e-cadherin expression in human cancer cells. British Journal of Surgery 82 (11), pp.1565-1565.
Jiang, W. G. et al. 1995. Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. British Journal of Cancer 71 (4), pp.744-752. (10.1038/bjc.1995.145)
Jiang, W. G. et al. 1995. Regulation of motility and invasion of cancer cells by human monocytic cells. Anticancer Research 15 (4), pp.1303-1310.
Jiang, W. G. et al. 1995. Expression of catenins in human cancer cells and its regulation by n-6 polyunsaturated fatty acids. Anticancer Research 15 (6B), pp.2569-2573.
Jiang, W. G. et al. 1995. Induction of tyrosine phosphorylation and translocation of ezrin by hepatocyte growth factor/scatter factor (HGF/SF). Biochemical and Biophysical Research Communications 217 (3), pp.1062-1069. (10.1006/bbrc.1995.2877)
Jiang, W. G. et al. 1995. Inhibition of HGF/SF-induced membrane ruffling and cell motility by transient elevation of cytosolic free Ca2+. Experimental Cell Research 220 (2), pp.424-433. (10.1006/excr.1995.1334)
Jiang, W. G. et al. 1995. Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA). Cancer Research 55 , pp.5043-5048.
Jiang, W. G. et al. 1995. Inhibition of HGF/SF-induced tumor-cell membrane ruffling by calcium signalling. British Journal of Surgery 82 (5), pp.682-683.

1994

Jiang, W. et al. 1994. Induction of motility and invasion by interleukin-3 on human colonic-cancer cells. British Journal of Surgery 81 (5), pp.761-761.
Jiang, W. G. 1994. In-vitro models of cancer invasion and metastasis: recent developments. European Journal of Surgical Oncology (EJSO) 20 , pp.493-499.
Jiang, W. G. , Puntis, M. C. A. and Hallett, M. B. 1994. Molecular and cellular basis of cancer invasion and metastasis: Implications for treatment. British Journal of Surgery 81 (11), pp.1576-1590. (10.1002/bjs.1800811107)
Jiang, W. G. and Puntis, M. D. A. 1994. Effects of gamma linolenic acid and lithium linolinate on human monocytes and hepatoma. In: Horrobin, D. F. ed. New approaches to cancer treatment: Unsaturated lipids and photodynamic therapy. Edinburgh: Churchill-Livingstone. , pp.40-67.
Jiang, W. G. , Puntis, M. C. A. and Hallett, M. B. 1994. Neutrophil priming by cytokines in patients with obstructive jaundice.. HPB Surgery 7 (4), pp.281-289. (10.1155/1994/74202)

1993

Jiang, W. G. et al. 1993. Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor. Clinical & Experimental Metastasis 11 (3), pp.235-242. (10.1007/BF00121166)
Jiang, W. G. , Hallett, M. B. and Puntis, M. C. A. 1993. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. British Journal of Surgery 80 (11), pp.1368-1373. (10.1002/bjs.1800801104)
Jiang, W. G. and Puntis, M. C. 1993. Monocyte secretion of beta-hexosaminidase in patients with obstructive jaundice. HPB Surgery 7 , pp.15-23.

1992

Jiang, W. G. et al. 1992. Neutrophil priming by hepatocyte growth factor, a novel cytokine. Immunology 77 (1), pp.147-149.
Jiang, W. G. , Puntis, M. and Hallett, M. B. 1992. U937 cells stimulated with opsonised zymozan particles provide a convenient laboratory source of tumour necrosis factor α. Journal of Immunological Methods 152 (2), pp.201-207. (10.1016/0022-1759(92)90141-F)

HGF/cMET in the osteoblastic metastasis of prostate cancer, molecular, cellular and therapeutic implications, in collaboration with Professor Malcolm D Mason
Molecular finger printing of genes linked to cancer progression
Novel molecular wound healing signature, in collaboration with Professor Keith Harding
The molecular, cellular and clinical impacts of SOCS, suppressor of cytokine signalling, in human wound healing, in collaboration with Professor Keith Harding
Anti-metastasis (including peritoneal metastasis) medicines, in collaboration with Peking University and Yiling Research Institute (Professor Jiafu Ji and Professor Yiling Wu)
Brain Metastasis Research Platform, in collaboration with Capital Medical University (Professors Junqi He and Wei Ding)
Evaluation of transglutaminase-4 as a therapeutic target and diagnostic tool in human prostate cancer, in collaboration with Professor Malcolm D Mason and Professor Richard J Ablin (University of Arizona)
Biomarkers in human colorectal cancer research programme, in collaboration with Capital Medical University (Professors Junqi He and Wei Ding)
Cancer Metastasis Platform, in collaboration with Wales Life Science Network

Molecular Pathology Module
Wound Healing Module
Cancer Biology Module

Education and qualifications:

1995, MD, University of Wales College of Medicine
1984, MB/ BCh in Clinical Medicine, Peking University Health Science Centre (Previously Beijing Medical University)

Career overview:

2014 - present: University Dean of International, Cardiff University
2012 - present: Director of Cardiff China Medical Research Collaborative
2012 - present: Quality and Safety Improvement Faculty, National Health Service/UHB, National Health Service
2012 - present: Academic Director for International Relations, Cardiff University
2004 - present: Professor of Surgery and Tumour Biology, Cardiff University School of Medicine
2003 - 2004: Reader, University of Wales College of Medicine
1997 - 2003: Senior Lecturer, University of Wales College of Medicine
1996 - 1997: Senior Fellow, University of Wales College of Medicine
1989 - 1996: Research Fellow, University of Wales College of Medicine (currently Cardiff University's School of Medicine)
1987 - 1989: Chief Surgical Resident, Department of General Surgery, Peking University First Hospital, Beijing
1984 - 1987: Surgical Resident, Department of General Surgery, Peking University First Hospital, Beijing

Honours and awards

Fellow of Learned Society of Wales
Fellow of the Royal Society of Biology
Fellow of the Royal Society of Medicine
Honorary professorship at Peking University
Honorary professorship at Capital Medical University
Honorary professorship at Inner Mongolia University
Honorary professorship at QingDao University
International consultant for Beijing Lung Cancer Centre

Recent awards include:

Member of the Most Excellent Order of the British Empire
Marquis Who's Who as Prominent Cancer Researcher
Outstanding Achievement Award, 19th World Congress of Oncology, Athens, Greece, October 2014
Super Professor in America's Academic Row, June 2015

Professional memberships

Member of the American Association for Cancer Research (AACR)
Member of the British Association for Cancer Research (BACR)
Member of the European Association for Cancer Research (EACR)

Committees and reviewing

2014 - present: Member of the University International Board

Other academic activities:

Editorship:

Editor-in-Chief: World Journal of Oncology
Editor-in-Chief: Cancer Metastasis, Biology and Treatment http://www.springer.com/series/5761
Editor-in-Chief: Journal of Molecular and Genetic Medicine http://www.omicsonline.com/open-access/molecular-genetic-medicine.php

Editorial Board membership includes:

Member of the editorial board of the International Journal of Molecular Medicine, from 1999
Advisory Board Member, 'Advances in Therapy', from 2008
Editorial Board Member, 'Current Oncology', from 2008
Editorial Board Member, 'Journal of Surgical Oncology', from 2008
Editorial Board Member, 'Current Signal Transduction Therapy', from 2009
Editorial Board Member, 'World Journal of Gastroenterology', from 2009
Editorial Board Member, 'Experimental and Therapeutic Medicine', from 2009
Editorial Board Member, 'World Journal of Clinical Oncology', From 2010
Editorial Board Member, 'World Journal of Oncology', From 2010
Editorial Board Member, 'Chinese Journal of Cancer Research', From 2010
Editorial Board Member, 'Current Cancer Therapy Reviews', From 2010
Editorial Board Member, ''International Journal of Oncology'', from 2011
Editorial Board Member, ''Translational Medicine: Current Research'', from 2011
Editorial Board Member, ''Translational Gastrointestinal Cancer'', from 2011
Editorial Board Member, ''Biomedical Reports'', from 2012
Editorial Board Member, ''World Journal of Medical Genetics (WJMG)'', from 2012
Academic consultant, 'Antitumour Pharmacy', from 2012
Editorial Board Member: 'Journal of Cancer Research and Therapy', from 2012
Editorial Board Member: 'Angiology', from 2012
Editorial Board Member: 'AO Translational Research', from 2013
Editorial Board Member: ' Chinese Journal of Biology', from 2013
Editorial Board Member: ' Academic Journal of Capital Medical University', from 2013
Editorial Board Member: ' Cancer Genomics and Proteomics', from 2014
Editorial Board Member: ' Insight of Medical Physics', from 2015
Editorial Board Member: ' Cancer Translational Medicine', from 2015
Editorial Board Member: ' 'Biochemical and Biophysical Acta (BBA) Clinical'', from 2015
Editorial Board Member: ' Cancer Hypothesis', from 2016

Books published

'Cancer Metastasis, molecular and cellular basis and clinical intervention' , Editors Wen G Jiang and Robert E Mansel, Kluwer Academic Publishers, 2000 (ISBN 0-7923-6395-7). (http://www.springer.com/gb/book/9780792363958)

'Growth Factors and their receptors in cancer metastasis', Editors Wen G Jiang, Toshikazu Nakamura and Kunio Matsumoto, Kluwer Academic Publishers, 2001 (ISBN 0-7923-7141-0) (http://www.springer.com/gb/book/9780792371410)

'Breast Cancer Metastasis' , Editors Robert E Mansel, Oystein Fodstad and Wen G Jiang, Spinger Publishers, 2007, ISBN: 978-1-4020-5866-0. (http://www.springer.com/gb/book/9781402058660)

'Electric Cell-Substrate Sensing in the investigation of cancer and cancer metastasis'. Wen G Jiang. Springer Publishers, 2012. ISBN 978-94-007-4926-9 (http://www.springer.com/biomed/cancer/book/978-94-007-4926-9)

'Tight junctions in cancer metastasis'. TA Martin and WG Jiang. Springer Publishers, March 2013 (ISBN 978-94-007-6027-1). (http://www.springer.com/gb/book/9789400760271)

Contact Details

[email protected]
+44 29206 87667
Henry Wellcome Building for Biomedical Research, Room Ground Floor, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN

Research themes

Specialisms

cancer
metastasis

Chinese investment in biomedical research

23 June 2017

Professor Wen Jiang
(he/him)

MBE, MB, BCh, MD, FRSB, FLSW

Teams and roles for Wen Jiang

Chair

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

1999

1998

1997

1996

1995

1994

1993

1992

Articles

Book sections

Conferences

Honours and awards

Professional memberships

Committees and reviewing

Contact Details

Research themes

Specialisms

Chinese investment in biomedical research

External profiles

Professor Wen Jiang (he/him) MBE, MB, BCh, MD, FRSB, FLSW

Teams and roles for Wen Jiang

Chair

Overview

Publication

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

1999

1998

1997

1996

1995

1994

1993

1992

Articles

Book sections

Conferences

Research

Teaching

Biography

Honours and awards

Professional memberships

Committees and reviewing

Contact Details

Research themes

Specialisms

Related news

Chinese investment in biomedical research

External profiles

Professor Wen Jiang
(he/him)

MBE, MB, BCh, MD, FRSB, FLSW